| Dr James D Decker, MD | |
|
211 Long Rapids Rd, Alpena, MI 49707-1315 | |
| (989) 354-2142 | |
| Not Available |
| Full Name | Dr James D Decker |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 211 Long Rapids Rd, Alpena, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497749576 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | JD075038 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice Of Northeastern Michigan | Gaylord, MI | Hospice |
| Midmichigan Medical Center - Alpena | Alpena, MI | Hospital |
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sound Inpatient Physicians-michigan Pllc | 5395896849 | 213 |
News Archive
In this interview, News-Medical talks to Santi Dominguez (SD) and Michael Graz (MG), CEOs at
Moderate and extreme ambient temperatures increase the risk of occupational accidents. This is the main conclusion of a new study by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Banking Foundation.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.
Most plastic and polymer materials around are poorly sustainable, as they are petroleum-based, their preparation needs metal catalysis, and they persist in the environment and cannot be effectively recycled. Seeking for true sustainability, American scientists have now prepared a fully recyclable biopolyester from a biofeedstock-based chemical without any metal catalyst involved.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of Michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013180181 PECOS PAC ID: 4486703170 Enrollment ID: O20090529000290 |
News Archive
In this interview, News-Medical talks to Santi Dominguez (SD) and Michael Graz (MG), CEOs at
Moderate and extreme ambient temperatures increase the risk of occupational accidents. This is the main conclusion of a new study by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Banking Foundation.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.
Most plastic and polymer materials around are poorly sustainable, as they are petroleum-based, their preparation needs metal catalysis, and they persist in the environment and cannot be effectively recycled. Seeking for true sustainability, American scientists have now prepared a fully recyclable biopolyester from a biofeedstock-based chemical without any metal catalyst involved.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
› Verified 2 days ago
| Entity Name | Sound Inpatient Physicians-michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639311996 PECOS PAC ID: 5395896849 Enrollment ID: O20090624000252 |
News Archive
In this interview, News-Medical talks to Santi Dominguez (SD) and Michael Graz (MG), CEOs at
Moderate and extreme ambient temperatures increase the risk of occupational accidents. This is the main conclusion of a new study by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Banking Foundation.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.
Most plastic and polymer materials around are poorly sustainable, as they are petroleum-based, their preparation needs metal catalysis, and they persist in the environment and cannot be effectively recycled. Seeking for true sustainability, American scientists have now prepared a fully recyclable biopolyester from a biofeedstock-based chemical without any metal catalyst involved.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
› Verified 2 days ago
| Entity Name | Sound Physicians Emergency Medicine Of Michigan, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568913473 PECOS PAC ID: 6800178195 Enrollment ID: O20170120002764 |
News Archive
In this interview, News-Medical talks to Santi Dominguez (SD) and Michael Graz (MG), CEOs at
Moderate and extreme ambient temperatures increase the risk of occupational accidents. This is the main conclusion of a new study by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Banking Foundation.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.
Most plastic and polymer materials around are poorly sustainable, as they are petroleum-based, their preparation needs metal catalysis, and they persist in the environment and cannot be effectively recycled. Seeking for true sustainability, American scientists have now prepared a fully recyclable biopolyester from a biofeedstock-based chemical without any metal catalyst involved.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of Michigan -tcg, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639658172 PECOS PAC ID: 3870920176 Enrollment ID: O20200226002368 |
News Archive
In this interview, News-Medical talks to Santi Dominguez (SD) and Michael Graz (MG), CEOs at
Moderate and extreme ambient temperatures increase the risk of occupational accidents. This is the main conclusion of a new study by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Banking Foundation.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.
Most plastic and polymer materials around are poorly sustainable, as they are petroleum-based, their preparation needs metal catalysis, and they persist in the environment and cannot be effectively recycled. Seeking for true sustainability, American scientists have now prepared a fully recyclable biopolyester from a biofeedstock-based chemical without any metal catalyst involved.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James D Decker, MD 211 Long Rapids Rd, Alpena, MI 49707-1315 Ph: () - | Dr James D Decker, MD 211 Long Rapids Rd, Alpena, MI 49707-1315 Ph: (989) 354-2142 |
News Archive
In this interview, News-Medical talks to Santi Dominguez (SD) and Michael Graz (MG), CEOs at
Moderate and extreme ambient temperatures increase the risk of occupational accidents. This is the main conclusion of a new study by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Banking Foundation.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.
Most plastic and polymer materials around are poorly sustainable, as they are petroleum-based, their preparation needs metal catalysis, and they persist in the environment and cannot be effectively recycled. Seeking for true sustainability, American scientists have now prepared a fully recyclable biopolyester from a biofeedstock-based chemical without any metal catalyst involved.
Galectin Therapeutics, the Cancer Centre at the Cliniques universitaires Saint-Luc and the Ludwig Institute for Cancer Research (LICR) announced today that they will initiate a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma.
› Verified 2 days ago
Jason L Beatty, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1185 Us Highway 23 N, Alpena, MI 49707 Phone: 989-736-8157 Fax: 989-358-3763 | |
Dr. Thomas J Cook, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 346 Long Rapids Plz, Alpena, MI 49707 Phone: 989-358-3500 | |
Dr. Doris V Coca-soto, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1185 Us Highway 23 N, Alpena, MI 49707 Phone: 989-356-4049 | |
Dr. Lynn E Field, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 Long Rapids Rd, Alpena, MI 49707 Phone: 989-354-2142 | |
Dr. Dick F Willis, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 Long Rapids Rd, Alpena, MI 49707 Phone: 989-354-2142 | |
Rong Lawson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Alpena Medical Arts, Pc, 211 Long Rapids Road, Alpena, MI 49707 Phone: 989-358-4251 Fax: 989-354-8600 | |
Dr. Tina M Rossi, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 Long Rapids Rd, Alpena, MI 49707 Phone: 989-354-2142 Fax: 989-354-6166 |